Annual Report 2003 of Beximco Pharmaceuticals Limited

It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2003. During 2003, BPL contributed Taka. 443.50 million in the form of import-related taxes, VAT and Income tax to the national exchequer. In 2003, The Company attained net sales of Taka. 2,183.80 million as against Taka. 2,508.79 million in 2002. Net Sales Revenue – Taka. 2,183,829,795. Cost of Goods Sold – Taka. 1,355,748,848. The pre-tax profit stood at Taka. 263.62 million in 2003 down from Taka. 362.23 million in 2002.

The dividend for 2002 was declared on 24-06-2003 and therefore, the dividend for 2002 was paid in 2003. The net dividend of Tk. 6,816 relating to the year 2002 was paid to 3 non-resident shareholders against 16,037 shares held by them after deduction of Income Tax at the source of Tk. 1,203. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Beximco Pharmaceuticals Limited :

  1. Annual Report 2001 of Beximco Pharmaceuticals Limited
  2. Annual Report 2002 of Beximco Pharmaceuticals Limited
  3. Annual Report 2003 of Beximco Pharmaceuticals Limited
  4. Annual Report 2004 of Beximco Pharmaceuticals Limited
  5. Annual Report 2005 of Beximco Pharmaceuticals Limited
  6. Annual Report 2006 of Beximco Pharmaceuticals Limited
  7. Annual Report 2007 of Beximco Pharmaceuticals Limited
  8. Annual Report 2008 of Beximco Pharmaceuticals Limited
  9. Annual Report 2009 of Beximco Pharmaceuticals Limited
  10. Annual Report 2010 of Beximco Pharmaceuticals Limited
  11. Annual Report 2011 of Beximco Pharmaceuticals Limited
  12. Annual Report 2012 of Beximco Pharmaceuticals Limited
  13. Annual Report 2013 of Beximco Pharmaceuticals Limited
  14. Annual Report 2014 of Beximco Pharmaceuticals Limited
  15. Auditors’ Report 2015 of Beximco Pharmaceuticals Limited
  16. Annual Report 2016 of Beximco Pharmaceuticals Limited
  17. Auditors’ Report 2017 of Beximco Pharmaceuticals Limited